Grant: Doctoral: Vanier Canada Graduate Scholarships
University of Calgary
$150,000.00
Deciphering the function of alpha B-crystallin in oligodendrocytes and its possible role in multiple sclerosis.
EF 2010-11
Résumé
Canada has one of the highest rates of multiple sclerosis (MS) worldwide. MS is a neurological disease in which self-reactive immune cells target and destroy oligodendrocytes. Oligodendrocytes produce myelin that insulates and supports neurons in the central nervous system (CNS). Studies suggest that prolonged oligodendrocyte injury and death may contribute to neuron degeneration. Therefore, oligodendrocyte protection and replacement are fundamental issues in MS to enhance therapy and disease perception. Alpha B-crystallin (alphaBC) is the highest up-regulated gene in oligodendrocytes and other CNS cells in active MS lesions. Also, the level of alphaBC increases as oligodendrocytes mature and myelinate. AlphaBC is a small heat shock protein that possesses a number of protective functions including pro-survival and anti-neurotoxic. Studies have shown that alphaBC promotes the survival of other CNS cells such as astrocytes and suppresses symptoms of the animal model of MS known as experimental autoimmune encephalomyelitis. We hypothesize that alphaBC may modulate the maturation, myelination and/or survival of oligodendrocytes. To investigate the role of alphaBC in myelination by oligodendrocytes the immune-mediated demyelinating agent, lysophosphatidylcholine, will be injected into the spinal cord of normal wild-type mice and mice lacking the alphaBC protein. The myelin content within the injured area will be quantified post-injection to analyze the demyelination and remyelination process. The number of immune cells as well as immature and mature oligodendrocytes will also be measured post-injection. The survival capability of oligodendrocytes is a crucial concern in MS research. Cell survival will be assessed in mature oligodendrocytes from normal wild-type and alphaBC-deficient mice that are grown in the presence of tumor necrosis factor to mimic the MS environment. This research will solidify a role for alphaBC in oligodendrocyte function and multiple sclerosis.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
217842
Name
Lichtenberger Trisha M
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Deciphering the function of alpha B-crystallin in oligodendrocytes and its possible role in multiple sclerosis.
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Alpha B-Crystallin; Cell Culture; Demyelination; Immunofluorescence; Immunology; Lysophosphatidylcholine; Multiple Sclerosis; Oligodendrocyte; Tunel Staining; Western Blotting
Abstract
Canada has one of the highest rates of multiple sclerosis (MS) worldwide. MS is a neurological disease in which self-reactive immune cells target and destroy oligodendrocytes. Oligodendrocytes produce myelin that insulates and supports neurons in the central nervous system (CNS). Studies suggest that prolonged oligodendrocyte injury and death may contribute to neuron degeneration. Therefore, oligodendrocyte protection and replacement are fundamental issues in MS to enhance therapy and disease perception. Alpha B-crystallin (alphaBC) is the highest up-regulated gene in oligodendrocytes and other CNS cells in active MS lesions. Also, the level of alphaBC increases as oligodendrocytes mature and myelinate. AlphaBC is a small heat shock protein that possesses a number of protective functions including pro-survival and anti-neurotoxic. Studies have shown that alphaBC promotes the survival of other CNS cells such as astrocytes and suppresses symptoms of the animal model of MS known as experimental autoimmune encephalomyelitis. We hypothesize that alphaBC may modulate the maturation, myelination and/or survival of oligodendrocytes. To investigate the role of alphaBC in myelination by oligodendrocytes the immune-mediated demyelinating agent, lysophosphatidylcholine, will be injected into the spinal cord of normal wild-type mice and mice lacking the alphaBC protein. The myelin content within the injured area will be quantified post-injection to analyze the demyelination and remyelination process. The number of immune cells as well as immature and mature oligodendrocytes will also be measured post-injection. The survival capability of oligodendrocytes is a crucial concern in MS research. Cell survival will be assessed in mature oligodendrocytes from normal wild-type and alphaBC-deficient mice that are grown in the presence of tumor necrosis factor to mimic the MS environment. This research will solidify a role for alphaBC in oligodendrocyte function and multiple sclerosis.
Competitiondate
201010
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Lichtenberger, Trisha M
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~